Anxiety is common among people newly diagnosed with amyotrophic lateral sclerosis (ALS) and their family members, a small study…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
A particular genetic variant that boosts the activity of the NEAT1 gene can push the onset of amyotrophic lateral…
Rapamycin, an approved medication used to prevent organ rejection after a kidney transplant, didn’t increase the number of regulatory…
Spinogenix has won a nearly $1 million grant from the U.S. Department of Defense (DoD) to move ahead with…
A first healthy volunteer has been dosed in a Phase 1 clinical study evaluating how safe and well tolerated is…
Note: This story was updated Sept. 25, 2023, to correct that TW001 uses the same active ingredient as Radicava and…
While eating a high-calorie diet is safe and well tolerated, it does not appear to slow disease progression or reduce…
A “velcro-like” protein called alpha-5 integrin consistently is found at high levels in immune cells near motor neurons being damaged…
InSilicoTrials and Axoltis Pharma are teaming up to advance the development of NX210c, the latter’s lead candidate for…
A professor at Massachusetts General Hospital and Harvard Medical School was awarded $10,000 by Mass General Brigham (MGB) for…